Please use this identifier to cite or link to this item:
|Title:||Sildenafil citrate diminishes microalbuminuria and the percentage of A1c in male patients with type 2 diabetes|
Villegas Rivera, G.
Guillen Ortiz, R.
|Abstract:||Sildenafil citrate has shown to display beneficial cardiovascular effects, suggesting that it may have other systemic benefits involving the endothelium. There is little data regarding the long-term use of this drug and the effects of this on different organs. Objective: The primary aim of this study was to determine whether sildenafil citrate diminishes concentrations of microalbuminuria and percentage of A1c in patients with type 2 diabetes. Design: A double-blind, randomized, controlled trial in 40 male patients, age 35-50, with type 2 diabetes. Subjects received sildenafil citrate 50 mg daily (n = 20) or placebo (n = 20) for 30 days. Levels of hs-CRP, microalbuminuria, homocysteine, A1c and erectile function were measured at baseline and to the end of the study. Results: Men that received sildenafil citrate displayed a significant decrease in the microalbuminuria concentrations (p < 0.01) versus baseline, (p = 0.02) versus placebo and A1c (p < 0.01) versus baseline, (p = 0.01) versus placebo. In addition, we observed a significant increase in the total IIEF score after 30 days of treatment (p < 0.01) versus baseline, (p < 0.01) versus placebo. Conclusions: The administration of 50 mg of sildenafil citrate for 30 consecutive days diminishes microalbuminuria and the percentage of A1c in patients with type 2 diabetes. © 2007 Elsevier Ireland Ltd. All rights reserved.|
|Appears in Collections:||Producción científica UdeG (prueba)|
Files in This Item:
There are no files associated with this item.
Items in RIUdeG are protected by copyright, with all rights reserved, unless otherwise indicated.